Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury: Mechanisms, Current Advances and Future Challenges

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Mar 13

PMID 36911700

Authors

Yuanliang Xia

Jianshu Zhu

Ruohan Yang

Hengyi Wang

Yuehong Li

Changfeng Fu

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) has considerable impact on patient physical, mental, and financial health. Secondary SCI is associated with inflammation, vascular destruction, and subsequent permanent damage to the nervous system. Mesenchymal stem cells (MSCs) have anti-inflammatory properties, promoting vascular regeneration and the release neuro-nutrients, and are a promising strategy for the treatment of SCI. Preclinical studies have shown that MSCs promote sensory and motor function recovery in rats. In clinical trials, MSCs have been reported to improve the American Spinal Injury Association (ASIA) sensory and motor scores. However, the effectiveness of MSCs in treating patients with SCI remains controversial. MSCs promote tumorigenesis and ensuring the survival of MSCs in the hostile environment of SCI is challenging. In this article we examine the evidence on the pathophysiological changes occurring after SCI. We then review the underlying mechanisms of MSCs in the treatment of SCI and summarize the potential application of MSCs in clinical practice. Finally, we highlight the challenges surrounding the use of MSCs in the treatment of SCI and discuss future applications.

Citing Articles

An Overview of Adult Acute Traumatic Neurologic Injury for the Anesthesiologist: .

Gomez C, Guo S, Jobarteh S, Lele A, Vavilala M, Theard M Curr Anesthesiol Rep. 2025; 15.

PMID: 39866534 PMC: 11759497. DOI: 10.1007/s40140-024-00667-4.

Advances in the research of immunomodulatory mechanism of mesenchymal stromal/stem cells on periodontal tissue regeneration.

Zhao D, Yang R, Wei H, Yang K, Yang Y, Wang N Front Immunol. 2025; 15():1449411.

PMID: 39830512 PMC: 11739081. DOI: 10.3389/fimmu.2024.1449411.

Application of extracellular vesicles in diabetic osteoporosis.

Jia X, Zhang G, Yu D Front Endocrinol (Lausanne). 2024; 15:1466775.

PMID: 39720256 PMC: 11666354. DOI: 10.3389/fendo.2024.1466775.

Bilobalide Activates Autophagy and Enhances the Efficacy of Bone Marrow Mesenchymal Stem Cells on Spinal Cord Injury Via Upregulating FMRP to Promote WNK1 mRNA Decay.

Chen M, Xu G, Guo W, Lin Y, Yao Z Neurochem Res. 2024; 50(1):33.

PMID: 39601946 DOI: 10.1007/s11064-024-04287-6.

The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases.

Ghosh M, Pearse D Cells. 2024; 13(22).

PMID: 39594583 PMC: 11592485. DOI: 10.3390/cells13221834.

References

Zhang C, Zhang C, Xu Y, Li C, Cao Y, Li P . Exosomes derived from human placenta-derived mesenchymal stem cells improve neurologic function by promoting angiogenesis after spinal cord injury. Neurosci Lett. 2020; 739:135399. DOI: 10.1016/j.neulet.2020.135399. View

Wang H, Xia Y, Li B, Li Y, Fu C . Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury. Front Bioeng Biotechnol. 2022; 10:812340. PMC: 9136098. DOI: 10.3389/fbioe.2022.812340. View

Okuda A, Horii-Hayashi N, Sasagawa T, Shimizu T, Shigematsu H, Iwata E . Bone marrow stromal cell sheets may promote axonal regeneration and functional recovery with suppression of glial scar formation after spinal cord transection injury in rats. J Neurosurg Spine. 2016; 26(3):388-395. DOI: 10.3171/2016.8.SPINE16250. View

Liu W, Wang Y, Gong F, Rong Y, Luo Y, Tang P . Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. J Neurotrauma. 2018; 36(3):469-484. DOI: 10.1089/neu.2018.5835. View

Kohno K, Shirasaka R, Yoshihara K, Mikuriya S, Tanaka K, Takanami K . A spinal microglia population involved in remitting and relapsing neuropathic pain. Science. 2022; 376(6588):86-90. DOI: 10.1126/science.abf6805. View

Amariglio N, Hirshberg A, Scheithauer B, Cohen Y, Loewenthal R, Trakhtenbrot L . Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6(2):e1000029. PMC: 2642879. DOI: 10.1371/journal.pmed.1000029. View

Albu S, Kumru H, Coll R, Vives J, Valles M, Benito-Penalva J . Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. Cytotherapy. 2020; 23(2):146-156. DOI: 10.1016/j.jcyt.2020.08.008. View

Jeong J, Jin C, Kim G, Lee J, Park C, Kim G . Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells. Int Immunopharmacol. 2010; 10(12):1580-6. DOI: 10.1016/j.intimp.2010.09.011. View

Khakoo A, Pati S, Anderson S, Reid W, Elshal M, Rovira I . Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203(5):1235-47. PMC: 2121206. DOI: 10.1084/jem.20051921. View

10.

Fitch M, Silver J . Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res. 1997; 290(2):379-84. DOI: 10.1007/s004410050944. View

11.

Luo Y, Xu T, Liu W, Rong Y, Wang J, Fan J . Exosomes derived from GIT1-overexpressing bone marrow mesenchymal stem cells promote traumatic spinal cord injury recovery in a rat model. Int J Neurosci. 2020; 131(2):170-182. DOI: 10.1080/00207454.2020.1734598. View

12.

Yoon S, Shim Y, Park Y, Chung J, Nam J, Kim M . Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells. 2007; 25(8):2066-73. DOI: 10.1634/stemcells.2006-0807. View

13.

Krupa P, Vackova I, Ruzicka J, Zaviskova K, Dubisova J, Koci Z . The Effect of Human Mesenchymal Stem Cells Derived from Wharton's Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application. Int J Mol Sci. 2018; 19(5). PMC: 5983761. DOI: 10.3390/ijms19051503. View

14.

Yao L, He C, Zhao Y, Wang J, Tang M, Li J . Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injury: Electrophysiological changes and long-term efficacy. Neural Regen Res. 2014; 8(5):397-403. PMC: 4146127. DOI: 10.3969/j.issn.1673-5374.2013.05.002. View

15.

Na L, Wang S, Liu T, Zhang L . Ultrashort Wave Combined with Human Umbilical Cord Mesenchymal Stem Cell (HUC-MSC) Transplantation Inhibits NLRP3 Inflammasome and Improves Spinal Cord Injury via MK2/TTP Signalling Pathway. Biomed Res Int. 2020; 2020:3021750. PMC: 7738785. DOI: 10.1155/2020/3021750. View

16.

Nie H, Jiang Z . Bone mesenchymal stem cell-derived extracellular vesicles deliver microRNA-23b to alleviate spinal cord injury by targeting toll-like receptor TLR4 and inhibiting NF-κB pathway activation. Bioengineered. 2021; 12(1):8157-8172. PMC: 8806461. DOI: 10.1080/21655979.2021.1977562. View

17.

Akhtar Anwar M, Al Shehabi T, Eid A . Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci. 2016; 10:98. PMC: 4829593. DOI: 10.3389/fncel.2016.00098. View

18.

Mohamadi Y, Noori Moghahi S, Mousavi M, Borhani-Haghighi M, Abolhassani F, Kashani I . Intrathecal transplantation of Wharton's jelly mesenchymal stem cells suppresses the NLRP1 inflammasome in the rat model of spinal cord injury. J Chem Neuroanat. 2019; 97:1-8. DOI: 10.1016/j.jchemneu.2019.01.011. View

19.

Wesseling P, van den Bent M, Perry A . Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015; 129(6):809-27. PMC: 4436696. DOI: 10.1007/s00401-015-1424-1. View

20.

Liddelow S, Guttenplan K, Clarke L, Bennett F, Bohlen C, Schirmer L . Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487. PMC: 5404890. DOI: 10.1038/nature21029. View